ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pruritus Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-11U11110
Home | Market Reports | Health| Health Conditions| Skin Conditions
Global Pruritus Therapeutics Sales Market Report 2022
BUY CHAPTERS

Global Pruritus Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-11U11110
Report
June 2025
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
J & J
Abbott
Amgen Inc
LEO Pharma
Novartis
Bayer
Pfizer Inc
UCB Pharma
GlaxoSmithKline PLC
Galderma
HUAPONT

Pruritus Therapeutics Market Size

In 2024, the global market size of Pruritus Therapeutics was estimated to be worth US$ 14790 million and is forecast to reach approximately US$ 19380 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.

Pruritus Therapeutics Market

Pruritus Therapeutics Market

Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
Market competition is intense. J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.
North America is the largest consumption place, with a revenue market share nearly 43%. Following North America, Europe is the second largest consumption place with the revenue market share of 27%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pruritus Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pruritus Therapeutics.
The Pruritus Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pruritus Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pruritus Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Pruritus Therapeutics Market Report

Report Metric Details
Report Name Pruritus Therapeutics Market
CAGR 4.0%
Segment by Type
  • Antihistamines
  • Corticosteroids
  • Calcineurin Inhibitors
  • Others
Segment by Application
  • External Use
  • Oral
  • Injection
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma, GlaxoSmithKline, Galderma, Huapont
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Pruritus Therapeutics in global and regional level.
  • Chapter 3: Detailed analysis of Pruritus Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pruritus Therapeutics revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the J&J, Abbott, Amgen, LEO Pharma share in Pruritus Therapeutics Market?

Ans: J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.

What is the Pruritus Therapeutics Market share by region?

Ans: North America is the largest consumption place, with a revenue market share nearly 43%.

Who are the main players in the Pruritus Therapeutics Market report?

Ans: The main players in the Pruritus Therapeutics Market are J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma, GlaxoSmithKline, Galderma, Huapont

What are the Application segmentation covered in the Pruritus Therapeutics Market report?

Ans: The Applications covered in the Pruritus Therapeutics Market report are External Use, Oral, Injection

What are the Type segmentation covered in the Pruritus Therapeutics Market report?

Ans: The Types covered in the Pruritus Therapeutics Market report are Antihistamines, Corticosteroids, Calcineurin Inhibitors, Others

1 Study Coverage
1.1 Pruritus Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Pruritus Therapeutics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Antihistamines
1.2.3 Corticosteroids
1.2.4 Calcineurin Inhibitors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pruritus Therapeutics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pruritus Therapeutics Market Size Estimates and Forecasts
2.2 Pruritus Therapeutics Market Size by Region: 2024 Versus 2031
2.2.1 Global Pruritus Therapeutics Revenue by Region: 2020-2025
2.2.2 Global Pruritus Therapeutics Revenue Forecast by Region (2026-2031)
2.2.3 Global Pruritus Therapeutics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Pruritus Therapeutics Revenue by Type (2020-2031)
3.1.2 Global Pruritus Therapeutics Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Pruritus Therapeutics Revenue by Application (2020-2031)
3.2.2 Global Pruritus Therapeutics Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Antihistamines of Pruritus Therapeutics Revenue Market Share by Application
3.3.2 Corticosteroids of Pruritus Therapeutics Revenue Market Share by Application
3.3.3 Calcineurin Inhibitors of Pruritus Therapeutics Revenue Market Share by Application
3.3.4 Others of Pruritus Therapeutics Revenue Market Share by Application
4 Global Pruritus Therapeutics by Company
4.1 Global Pruritus Therapeutics Revenue by Company (2020-2025)
4.2 Global Pruritus Therapeutics Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Pruritus Therapeutics Companies around the World: Ranking by Revenue
4.3.2 Global Pruritus Therapeutics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Pruritus Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Pruritus Therapeutics Companies Headquarters & Product Type
4.4.1 Global Pruritus Therapeutics Companies Headquarters
4.4.2 Date of International Companies Enter into Pruritus Therapeutics Market
4.4.3 Global Pruritus Therapeutics Companies Product & Service
4.4.4 Antihistamines Revenue Market Share of Pruritus Therapeutics by Company
4.4.5 Corticosteroids Revenue Market Share of Pruritus Therapeutics by Company
4.4.6 Calcineurin Inhibitors Revenue Market Share of Pruritus Therapeutics by Company
4.4.7 Others Revenue Market Share of Pruritus Therapeutics by Company
4.5 Global Pruritus Therapeutics Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 J&J
5.1.1 J&J Corporation Information
5.1.2 J&J Description, Business Overview
5.1.3 J&J Pruritus Therapeutics Products Offered
5.1.4 J&J Pruritus Therapeutics Revenue and Gross Margin (2020-2025)
5.1.5 J&J Pruritus Therapeutics Revenue by Product in 2024
5.1.6 J&J Pruritus Therapeutics Revenue by Application in 2024
5.1.7 J&J Pruritus Therapeutics Revenue by Geographic Area in 2024
5.1.8 J&J Recent Developments
5.2 Abbott
5.2.1 Abbott Corporation Information
5.2.2 Abbott Description, Business Overview
5.2.3 Abbott Pruritus Therapeutics Products Offered
5.2.4 Abbott Pruritus Therapeutics Revenue and Gross Margin (2020-2025)
5.2.5 Abbott Pruritus Therapeutics Revenue by Product in 2024
5.2.6 Abbott Pruritus Therapeutics Revenue by Application in 2024
5.2.7 Abbott Pruritus Therapeutics Revenue by Geographic Area in 2024
5.2.8 Abbott Recent Developments
5.3 Amgen
5.3.1 Amgen Corporation Information
5.3.2 Amgen Description, Business Overview
5.3.3 Amgen Pruritus Therapeutics Products Offered
5.3.4 Amgen Pruritus Therapeutics Revenue and Gross Margin (2020-2025)
5.3.5 Amgen Pruritus Therapeutics Revenue by Product in 2024
5.3.6 Amgen Pruritus Therapeutics Revenue by Application in 2024
5.3.7 Amgen Pruritus Therapeutics Revenue by Geographic Area in 2024
5.3.8 Amgen Recent Developments
5.4 LEO Pharma
5.4.1 LEO Pharma Corporation Information
5.4.2 LEO Pharma Description, Business Overview
5.4.3 LEO Pharma Pruritus Therapeutics Products Offered
5.4.4 LEO Pharma Pruritus Therapeutics Revenue and Gross Margin (2020-2025)
5.4.5 LEO Pharma Pruritus Therapeutics Revenue by Product in 2024
5.4.6 LEO Pharma Pruritus Therapeutics Revenue by Application in 2024
5.4.7 LEO Pharma Pruritus Therapeutics Revenue by Geographic Area in 2024
5.4.8 LEO Pharma Recent Developments
5.5 Novartis
5.5.1 Novartis Corporation Information
5.5.2 Novartis Description, Business Overview
5.5.3 Novartis Pruritus Therapeutics Products Offered
5.5.4 Novartis Pruritus Therapeutics Revenue and Gross Margin (2020-2025)
5.5.5 Novartis Pruritus Therapeutics Revenue by Product in 2024
5.5.6 Novartis Pruritus Therapeutics Revenue by Application in 2024
5.5.7 Novartis Pruritus Therapeutics Revenue by Geographic Area in 2024
5.5.8 Novartis Recent Developments
5.6 Bayer
5.6.1 Bayer Corporation Information
5.6.2 Bayer Description, Business Overview
5.6.3 Bayer Pruritus Therapeutics Products Offered
5.6.4 Bayer Pruritus Therapeutics Revenue and Gross Margin (2020-2025)
5.6.5 Bayer Pruritus Therapeutics Revenue by Product in 2024
5.6.6 Bayer Pruritus Therapeutics Revenue by Application in 2024
5.6.7 Bayer Pruritus Therapeutics Revenue by Geographic Area in 2024
5.6.8 Bayer Recent Developments
5.7 Pfizer
5.7.1 Pfizer Corporation Information
5.7.2 Pfizer Description, Business Overview
5.7.3 Pfizer Pruritus Therapeutics Products Offered
5.7.4 Pfizer Pruritus Therapeutics Revenue and Gross Margin (2020-2025)
5.7.5 Pfizer Pruritus Therapeutics Revenue by Product in 2024
5.7.6 Pfizer Pruritus Therapeutics Revenue by Application in 2024
5.7.7 Pfizer Pruritus Therapeutics Revenue by Geographic Area in 2024
5.7.8 Pfizer Recent Developments
5.8 UCB Pharma
5.8.1 UCB Pharma Corporation Information
5.8.2 UCB Pharma Description, Business Overview
5.8.3 UCB Pharma Pruritus Therapeutics Products Offered
5.8.4 UCB Pharma Pruritus Therapeutics Revenue and Gross Margin (2020-2025)
5.8.5 UCB Pharma Pruritus Therapeutics Revenue by Product in 2024
5.8.6 UCB Pharma Pruritus Therapeutics Revenue by Application in 2024
5.8.7 UCB Pharma Pruritus Therapeutics Revenue by Geographic Area in 2024
5.8.8 UCB Pharma Recent Developments
5.9 GlaxoSmithKline
5.9.1 GlaxoSmithKline Corporation Information
5.9.2 GlaxoSmithKline Description, Business Overview
5.9.3 GlaxoSmithKline Pruritus Therapeutics Products Offered
5.9.4 GlaxoSmithKline Pruritus Therapeutics Revenue and Gross Margin (2020-2025)
5.9.5 GlaxoSmithKline Pruritus Therapeutics Revenue by Product in 2024
5.9.6 GlaxoSmithKline Pruritus Therapeutics Revenue by Application in 2024
5.9.7 GlaxoSmithKline Pruritus Therapeutics Revenue by Geographic Area in 2024
5.9.8 GlaxoSmithKline Recent Developments
5.10 Galderma
5.10.1 Galderma Corporation Information
5.10.2 Galderma Description, Business Overview
5.10.3 Galderma Pruritus Therapeutics Products Offered
5.10.4 Galderma Pruritus Therapeutics Revenue and Gross Margin (2020-2025)
5.10.5 Galderma Pruritus Therapeutics Revenue by Product in 2024
5.10.6 Galderma Pruritus Therapeutics Revenue by Application in 2024
5.10.7 Galderma Pruritus Therapeutics Revenue by Geographic Area in 2024
5.10.8 Galderma Recent Developments
5.11 Huapont
5.11.1 Huapont Corporation Information
5.11.2 Huapont Description, Business Overview
5.11.3 Huapont Pruritus Therapeutics Products Offered
5.11.4 Huapont Pruritus Therapeutics Revenue and Gross Margin (2020-2025)
5.11.5 Huapont Pruritus Therapeutics Revenue by Product in 2024
5.11.6 Huapont Pruritus Therapeutics Revenue by Application in 2024
5.11.7 Huapont Pruritus Therapeutics Revenue by Geographic Area in 2024
5.11.8 Huapont Recent Developments
6 North America
6.1 North America Pruritus Therapeutics Market Size YoY Growth 2020-2031
6.2 North America Pruritus Therapeutics Market Facts & Figures by Country (2020-2031)
6.3 North America Pruritus Therapeutics Revenue by Type (2020-2025)
6.4 North America Pruritus Therapeutics Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Pruritus Therapeutics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Pruritus Therapeutics Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Pruritus Therapeutics Revenue by Type (2020-2025)
7.4 Asia-Pacific Pruritus Therapeutics Revenue by Application (2020-2025)
8 Europe
8.1 Europe Pruritus Therapeutics Market Size YoY Growth 2020-2031
8.2 Europe Pruritus Therapeutics Market Facts & Figures by Country (2020-2031)
8.3 Europe Pruritus Therapeutics Revenue by Type (2020-2025)
8.4 Europe Pruritus Therapeutics Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Pruritus Therapeutics Market Size YoY Growth 2020-2031
9.2 Latin America Pruritus Therapeutics Market Facts & Figures by Country (2020-2031)
9.3 Latin America Pruritus Therapeutics Revenue by Type (2020-2025)
9.4 Latin America Pruritus Therapeutics Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Pruritus Therapeutics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Pruritus Therapeutics Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Pruritus Therapeutics Revenue by Type (2020-2025)
10.4 Middle East and Africa Pruritus Therapeutics Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Pruritus Therapeutics Supply Chain Analysis
11.2 Pruritus Therapeutics Key Raw Materials and Upstream Suppliers
11.3 Pruritus Therapeutics Clients Analysis
11.4 Pruritus Therapeutics Sales Channel and Sales Model Analysis
11.4.1 Pruritus Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Pruritus Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Pruritus Therapeutics Distributors
12 Pruritus Therapeutics Market Dynamics
12.1 Pruritus Therapeutics Industry Trends
12.2 Pruritus Therapeutics Market Drivers
12.3 Pruritus Therapeutics Market Challenges
12.4 Pruritus Therapeutics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
J & J
Abbott
Amgen Inc
LEO Pharma
Novartis
Bayer
Pfizer Inc
UCB Pharma
GlaxoSmithKline PLC
Galderma
HUAPONT
List of Tables
 Table 1. Global Pruritus Therapeutics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Pruritus Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Pruritus Therapeutics Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Pruritus Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Pruritus Therapeutics Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Pruritus Therapeutics Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Pruritus Therapeutics Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Pruritus Therapeutics Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Pruritus Therapeutics Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Pruritus Therapeutics Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Pruritus Therapeutics Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Pruritus Therapeutics Players by Revenue (US$ Million) in 2024
 Table 13. Global Pruritus Therapeutics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Pruritus Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pruritus Therapeutics as of 2024)
 Table 15. Global Pruritus Therapeutics Companies Headquarters
 Table 16. Date of International Companies Enter into Pruritus Therapeutics Market
 Table 17. Global Pruritus Therapeutics Companies Product & Service
 Table 18. Global Pruritus Therapeutics Mergers & Acquisitions, Expansion Plans
 Table 19. J&J Corporation Information
 Table 20. J&J Description and Business Overview
 Table 21. J&J Pruritus Therapeutics Product
 Table 22. J&J Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. J&J Revenue Proportion of Pruritus Therapeutics by Product in 2024
 Table 24. J&J Revenue Proportion of Pruritus Therapeutics by Application in 2024
 Table 25. J&J Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2024
 Table 26. J&J Recent Developments
 Table 27. Abbott Corporation Information
 Table 28. Abbott Description and Business Overview
 Table 29. Abbott Pruritus Therapeutics Product
 Table 30. Abbott Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Abbott Revenue Proportion of Pruritus Therapeutics by Product in 2024
 Table 32. Abbott Revenue Proportion of Pruritus Therapeutics by Application in 2024
 Table 33. Abbott Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2024
 Table 34. Abbott Recent Developments
 Table 35. Amgen Corporation Information
 Table 36. Amgen Description and Business Overview
 Table 37. Amgen Pruritus Therapeutics Product
 Table 38. Amgen Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Amgen Revenue Proportion of Pruritus Therapeutics by Product in 2024
 Table 40. Amgen Revenue Proportion of Pruritus Therapeutics by Application in 2024
 Table 41. Amgen Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2024
 Table 42. Amgen Recent Developments
 Table 43. LEO Pharma Corporation Information
 Table 44. LEO Pharma Description and Business Overview
 Table 45. LEO Pharma Pruritus Therapeutics Product
 Table 46. LEO Pharma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. LEO Pharma Revenue Proportion of Pruritus Therapeutics by Product in 2024
 Table 48. LEO Pharma Revenue Proportion of Pruritus Therapeutics by Application in 2024
 Table 49. LEO Pharma Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2024
 Table 50. LEO Pharma Recent Developments
 Table 51. Novartis Corporation Information
 Table 52. Novartis Description and Business Overview
 Table 53. Novartis Pruritus Therapeutics Product
 Table 54. Novartis Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Novartis Revenue Proportion of Pruritus Therapeutics by Product in 2024
 Table 56. Novartis Revenue Proportion of Pruritus Therapeutics by Application in 2024
 Table 57. Novartis Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2024
 Table 58. Novartis Recent Developments
 Table 59. Bayer Corporation Information
 Table 60. Bayer Description and Business Overview
 Table 61. Bayer Pruritus Therapeutics Product
 Table 62. Bayer Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Bayer Revenue Proportion of Pruritus Therapeutics by Product in 2024
 Table 64. Bayer Revenue Proportion of Pruritus Therapeutics by Application in 2024
 Table 65. Bayer Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2024
 Table 66. Bayer Recent Developments
 Table 67. Pfizer Corporation Information
 Table 68. Pfizer Description and Business Overview
 Table 69. Pfizer Pruritus Therapeutics Product
 Table 70. Pfizer Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Pfizer Revenue Proportion of Pruritus Therapeutics by Product in 2024
 Table 72. Pfizer Revenue Proportion of Pruritus Therapeutics by Application in 2024
 Table 73. Pfizer Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2024
 Table 74. Pfizer Recent Developments
 Table 75. UCB Pharma Corporation Information
 Table 76. UCB Pharma Description and Business Overview
 Table 77. UCB Pharma Pruritus Therapeutics Product
 Table 78. UCB Pharma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. UCB Pharma Revenue Proportion of Pruritus Therapeutics by Product in 2024
 Table 80. UCB Pharma Revenue Proportion of Pruritus Therapeutics by Application in 2024
 Table 81. UCB Pharma Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2024
 Table 82. UCB Pharma Recent Developments
 Table 83. GlaxoSmithKline Corporation Information
 Table 84. GlaxoSmithKline Description and Business Overview
 Table 85. GlaxoSmithKline Pruritus Therapeutics Product
 Table 86. GlaxoSmithKline Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. GlaxoSmithKline Revenue Proportion of Pruritus Therapeutics by Product in 2024
 Table 88. GlaxoSmithKline Revenue Proportion of Pruritus Therapeutics by Application in 2024
 Table 89. GlaxoSmithKline Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2024
 Table 90. GlaxoSmithKline Recent Developments
 Table 91. Galderma Corporation Information
 Table 92. Galderma Description and Business Overview
 Table 93. Galderma Pruritus Therapeutics Product
 Table 94. Galderma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. Galderma Revenue Proportion of Pruritus Therapeutics by Product in 2024
 Table 96. Galderma Revenue Proportion of Pruritus Therapeutics by Application in 2024
 Table 97. Galderma Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2024
 Table 98. Galderma Recent Developments
 Table 99. Huapont Corporation Information
 Table 100. Huapont Description and Business Overview
 Table 101. Huapont Pruritus Therapeutics Product
 Table 102. Huapont Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Huapont Revenue Proportion of Pruritus Therapeutics by Product in 2024
 Table 104. Huapont Revenue Proportion of Pruritus Therapeutics by Application in 2024
 Table 105. Huapont Revenue Proportion of Pruritus Therapeutics by Geographic Area in 2024
 Table 106. Huapont Recent Developments
 Table 107. North America Pruritus Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 108. North America Pruritus Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 109. North America Pruritus Therapeutics Revenue by Type (2020-2025) & (US$ Million)
 Table 110. North America Pruritus Therapeutics Revenue by Application (2020-2025) & (US$ Million)
 Table 111. Asia-Pacific Pruritus Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 112. Asia-Pacific Pruritus Therapeutics Revenue by Region (2026-2031) & (US$ Million)
 Table 113. Asia-Pacific Pruritus Therapeutics Revenue by Type (2020-2025) & (US$ Million)
 Table 114. Asia-Pacific Pruritus Therapeutics Revenue by Application (2020-2025) & (US$ Million)
 Table 115. Europe Pruritus Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 116. Europe Pruritus Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 117. Europe Pruritus Therapeutics Revenue by Type (2020-2025) & (US$ Million)
 Table 118. Europe Pruritus Therapeutics Revenue by Application (2020-2025) & (US$ Million)
 Table 119. Latin America Pruritus Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 120. Latin America Pruritus Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 121. Latin America Pruritus Therapeutics Revenue by Type (2020-2025) & (US$ Million)
 Table 122. Latin America Pruritus Therapeutics Revenue by Application (2020-2025) & (US$ Million)
 Table 123. Middle East and Africa Pruritus Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 124. Middle East and Africa Pruritus Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 125. Middle East and Africa Pruritus Therapeutics Revenue by Type (2020-2025) & (US$ Million)
 Table 126. Middle East and Africa Pruritus Therapeutics Revenue by Application (2020-2025) & (US$ Million)
 Table 127. Pruritus Therapeutics Key Raw Materials, Industry Status and Trend
 Table 128. Pruritus Therapeutics Key Raw Materials and Upstream Suppliers
 Table 129. Pruritus Therapeutics Clients Status and Trend
 Table 130. Pruritus Therapeutics Typical Clients
 Table 131. Pruritus Therapeutics Distributors
 Table 132. Pruritus Therapeutics Market Trends
 Table 133. Pruritus Therapeutics Market Drivers
 Table 134. Pruritus Therapeutics Market Challenges
 Table 135. Pruritus Therapeutics Market Restraints
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pruritus Therapeutics Product Picture
 Figure 2. Global Pruritus Therapeutics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Pruritus Therapeutics Revenue Market Share by Type in 2024 & 2031
 Figure 4. Antihistamines Product Picture
 Figure 5. Corticosteroids Product Picture
 Figure 6. Calcineurin Inhibitors Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Pruritus Therapeutics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 9. Global Pruritus Therapeutics Revenue Market Share by Application in 2024 & 2031
 Figure 10. External Use
 Figure 11. Oral
 Figure 12. Injection
 Figure 13. Pruritus Therapeutics Report Years Considered
 Figure 14. Global Pruritus Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pruritus Therapeutics Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Pruritus Therapeutics Market Size Market Share by Region: 2024 Versus 2031
 Figure 17. Global Pruritus Therapeutics Revenue Market Share by Region (2020-2031)
 Figure 18. Global Pruritus Therapeutics Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Global Pruritus Therapeutics Revenue Market Share Forecast by Application (2020-2031)
 Figure 20. Antihistamines of Pruritus Therapeutics Revenue Market Share by Application, 2024 VS 2031
 Figure 21. Corticosteroids of Pruritus Therapeutics Revenue Market Share by Application, 2024 VS 2031
 Figure 22. Calcineurin Inhibitors of Pruritus Therapeutics Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Others of Pruritus Therapeutics Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Pruritus Therapeutics Revenue Share by Company (2024)
 Figure 25. Pruritus Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Antihistamines Revenue Proportion by Company in 2024
 Figure 27. Corticosteroids Revenue Proportion by Company in 2024
 Figure 28. Calcineurin Inhibitors Revenue Proportion by Company in 2024
 Figure 29. Others Revenue Proportion by Company in 2024
 Figure 30. North America Pruritus Therapeutics Revenue 2020-2031 (US$ Million)
 Figure 31. North America Pruritus Therapeutics Revenue Market Share by Type (2020-2025)
 Figure 32. North America Pruritus Therapeutics Revenue Market Share by Application (2020-2025)
 Figure 33. Asia-Pacific Pruritus Therapeutics Revenue 2020-2031 (US$ Million)
 Figure 34. Asia-Pacific Pruritus Therapeutics Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Pruritus Therapeutics Revenue Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Pruritus Therapeutics Revenue Market Share by Application (2020-2025)
 Figure 37. Europe Pruritus Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Pruritus Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 39. Europe Pruritus Therapeutics Revenue Market Share by Type (2020-2025)
 Figure 40. Europe Pruritus Therapeutics Revenue Market Share by Application (2020-2025)
 Figure 41. Latin America Pruritus Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America Pruritus Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 43. Latin America Pruritus Therapeutics Revenue Market Share by Type (2020-2025)
 Figure 44. Latin America Pruritus Therapeutics Revenue Market Share by Application (2020-2025)
 Figure 45. Middle East and Africa Pruritus Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 46. Middle East and Africa Pruritus Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Pruritus Therapeutics Revenue Market Share by Type (2020-2025)
 Figure 48. Middle East and Africa Pruritus Therapeutics Revenue Market Share by Application (2020-2025)
 Figure 49. Pruritus Therapeutics Supply Chain (Upstream and Downstream Market)
 Figure 50. Global Production Market Share of Pruritus Therapeutics Raw Materials by Region in 2024
 Figure 51. Pruritus Therapeutics Distribution Channels
 Figure 52. Global Pruritus Therapeutics Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 53. Global Pruritus Therapeutics Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Anti itch Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antipruritic Ointment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti itch Ointment Market Research Report 2025
Global Pruritus Drugs Market Insights Forecast to 2030
Global Pruritus Type Skin Diseases Medicine Market Research Report 2024
Global Anti Itch Creams and Lotions Market Research Report 2024
Topical Pain Relief Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pruritus Ani Medicine Market Research Report 2024
Global Topical Pain Relief Gel Market Research Report 2024
Medications for Prurigo Nodularis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prurigo Nodularis Treatment Market Research Report 2024
Global Dermatitis Drugs Market Research Report 2024
Global Analgesic Creams Market Insights Forecast to 2030
Itch Relief Cream Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Atopic Dermatitis Therapeutics Market Insights Forecast to 2030
Aquagenic Pruritus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adult Anti Itch Ointment Market Research Report 2024
Nodular Prurigo Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Skin Tears Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pramoxine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Chronic Idiopathic Urticaria Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38H16391
Tue Sep 23 00:00:00 UTC 2025

Add to Cart

Global Fungal Skin Disease Diagnostic Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17T16810
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Global UVB Vitiligo Phototherapy Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z16496
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Global Vitiligo Phototherapy Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15I16746
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions